Nasdaq's Discretionary Listing Authority — What the December 2025 Anti-Manipulation Rule Means for Issuers

What the Rule Does — and Why Nasdaq Adopted It

National securities exchanges have always had some degree of qualitative discretion over listing decisions. Exchange rulebooks generally contain public interest clauses that allow denial of a listing when the exchange determines that approval would not be in the public interest or would be contrary to the protection of investors, even if all quantitative standards are met. What Nasdaq's December 2025 rule does is formalize and expand this discretion in the specific context of market manipulation risk — making it explicit that Nasdaq can and will exercise qualitative judgment over listing applicants when it identifies patterns suggesting potential manipulation.

The proximate cause of the rule was a pattern of IPO listing incidents that Nasdaq observed from approximately 2022 through 2025. A number of smaller IPOs — disproportionately involving international companies listing on Nasdaq Capital Market — exhibited strikingly similar post-IPO trading patterns: shares would trade at or near the IPO price for the first few hours of the first trading day, then experience a sudden and extreme price surge — sometimes 500% to 1,000% or more above the IPO price — driven by concentrated buying in thin trading conditions. The surge would persist for a short period, then reverse sharply, leaving retail investors who had purchased at elevated prices with substantial losses.

These patterns had several characteristics in common. The float was typically very small — often 10 to 20% of outstanding shares, with the remainder held in concentrated blocks by insiders or affiliated parties subject to lock-up agreements. The underwriters were frequently boutique or foreign firms with limited U.S. institutional distribution relationships. The issuers were often small companies from Asia-Pacific markets with minimal pre-IPO U.S. investor recognition. And the post-IPO trading was often concentrated among a small number of accounts. Nasdaq's analysis concluded that many of these episodes involved coordinated buying intended to inflate the post-IPO price, allowing early shareholders or affiliated parties to benefit at the expense of retail investors who purchased into the run-up.

The December 2025 rule creates an explicit mechanism for Nasdaq to identify and decline to list companies where this pattern of risk is present, without waiting for post-listing enforcement action by the SEC or FINRA. It positions the exchange as a proactive gatekeeper rather than a passive rule-applier.

What Nasdaq Evaluates — The Qualitative Assessment Framework

Nasdaq's discretionary evaluation under the December 2025 rule considers several categories of factors, many of which are not captured in the quantitative listing standards that have historically defined the gatekeeping function.

The backgrounds and track records of significant shareholders receive particular attention. When a company's shareholder register includes individuals or entities associated with prior listings that experienced the manipulative trading patterns described above — or that have been subject to SEC or FINRA enforcement action — that history is relevant to Nasdaq's assessment regardless of whether the current applicant has directly engaged in prior violations. The exchange is evaluating the risk profile of the ecosystem surrounding the listing, not only the issuer itself.

The selection of underwriters and key advisors also enters the analysis. Underwriters have direct influence over IPO pricing, share allocation, and distribution to investors. When an issuer selects an underwriter with a history of small-float IPOs that subsequently experienced manipulative trading, or when the underwriter's client list overlaps significantly with the problematic IPO cohort Nasdaq has identified, that connection may trigger additional scrutiny. The rule effectively creates reputational consequences for intermediaries, not only for issuers.

Structural features of the offering are evaluated as potential risk indicators. A free float that is very small relative to total outstanding shares — creating the thin trading conditions that make price manipulation easier — is a recognized risk factor. Lock-up arrangements that are unusually short or that contain carve-outs allowing large shareholders to sell quickly after listing create conditions for post-IPO price manipulation. Concentrated ownership by a small number of related parties, combined with a small public float, is the structural configuration most associated with the manipulation patterns the rule is designed to prevent.

The company's trading history in its home market, if applicable, is also relevant. Companies that experienced unusual price volatility, trading halts for manipulation concerns, or regulatory scrutiny in their home market carry that history into the Nasdaq application process. The December 2025 rule does not provide a comprehensive list of disqualifying factors — it establishes a framework for qualitative judgment, which by design cannot be reduced to a checklist.

How Issuers Should Prepare

The most important implication of the December 2025 rule for companies planning a Nasdaq listing is timing: the exchange-level evaluation that the rule enables must be anticipated and addressed before — not after — the registration statement is filed. A company that files its S-1 or F-1, completes SEC review, and then submits a listing application only to face a Nasdaq qualitative inquiry has significantly fewer options than a company that engaged the exchange proactively a year before the filing.

Proactive engagement with Nasdaq's listing qualifications team, typically through the company's U.S. securities counsel, should begin early in the preparation process. This engagement can surface concerns about specific shareholders, advisors, or structural features before those concerns have hardened into a formal denial recommendation. Nasdaq has an interest in approving clean listings — the rule is designed to screen out manipulation risk, not to impose new barriers for legitimate issuers. Companies that can demonstrate a clean shareholder base, reputable advisors, a meaningful float, and an absence of home-market regulatory history are well-positioned to navigate the qualitative review without difficulty.

For companies where the shareholder register includes names that may trigger scrutiny, the preparation period is the time to assess whether structural changes — such as encouraging certain shareholders to reduce their positions before the IPO or adjusting the float size — would improve the listing prospects. These decisions are much easier to make 12 to 18 months before the listing date than in the weeks before a planned offering.

• Choose underwriters with established U.S. institutional distribution records. Boutique underwriters with limited institutional relationships may be less expensive but create Nasdaq scrutiny risk that outweighs any cost saving.
• Structure the offering float to reflect genuine distribution intent. A float below 20% of outstanding shares will receive heightened attention. IPOs designed to place shares with a broad institutional base rather than a narrow group of affiliated buyers are structurally less susceptible to the patterns the rule targets.
• Conduct a shareholder registry review before filing. Understand whether any current shareholders have associations with prior manipulative listings and whether those associations are likely to be identified in Nasdaq's evaluation process.
• Document home-market regulatory history. If the company or its key insiders have been subject to regulatory inquiry in their home jurisdiction, U.S. securities counsel should advise on disclosure obligations and on how to address these in the Nasdaq application context.

Nasdaq vs. NYSE — How the Two Exchanges Differ

NYSE has long maintained a public interest and investor protection standard that allows the exchange to deny listings on qualitative grounds. The New York Stock Exchange Listing Company Manual provides that NYSE may deny a listing if it determines that listing would be inconsistent with the protection of investors, or that the exchange otherwise determines listing is inadvisable. This standard has been used by NYSE on relatively rare occasions, typically involving companies with significant pending regulatory or legal issues.

The December 2025 Nasdaq rule brings the two exchanges into closer alignment on the formal existence of this discretionary authority. Before December 2025, Nasdaq's rules were arguably less explicit than NYSE's on the scope of qualitative listing discretion, creating an argument that companies meeting all quantitative standards had a stronger claim to Nasdaq listing approval than to NYSE approval. The new rule eliminates that asymmetry.

The two exchanges continue to differ in practical emphasis. NYSE, as the exchange of choice for larger-cap listings, exercises its public interest discretion primarily in the context of companies with complex pending litigation, regulatory investigations, or governance failures. Nasdaq, as the exchange that serves a larger portion of smaller-cap and international IPO activity, is applying its new discretionary authority more directly to the manipulation-risk profile that has emerged from its analysis of the small-float IPO cohort.

For companies that qualify for both exchanges under quantitative standards, the December 2025 Nasdaq rule adds a new dimension to the exchange selection decision. Companies whose shareholder base, advisor relationships, or operational profile might trigger Nasdaq's new qualitative scrutiny — but who can satisfy NYSE's listing standards — should evaluate both options with their advisors rather than defaulting to Nasdaq. The exchange selection is a strategic decision that now carries a compliance dimension it did not carry before December 2025.